Immix Biopharma, Inc.IMMXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-15.45M
↓ 105% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-7.55M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-15.45M | +2.0% |
| 2024 | $-15.77M | -38.1% |
| 2023 | $-11.42M | -54.2% |
| 2022 | $-7.41M | -365.9% |
| 2021 | $-1.59M | -292.9% |
| 2020 | $-404694.00 | +49.2% |
| 2019 | $-797340.00 | - |